News

Spectrum is now in a position to conduct a phase I/II trial with D 63153 in hormone-dependent prostate cancer and, thereby, expand the clinical development of D 63153

In October 2004, the FDA informed La Jolla that Riquent (abetimus sodium) was “approvable” pending the successful completion of a clinical benefit trial. A clinical benefit trial designed

The VR1 receptor is an ion channel protein that mediates and influences cell signaling, including the nerve cell signaling that generates some types of pain. Inhibitors of VR1

The objectives of the phase I clinical protocol are to evaluate safety, pharmacokinetics and viral load in patients chronically infected with Hepatitis C virus (HCV) who have failed

A similar phase I clinical trial for Neumune is currently ongoing in the Netherlands. Acute Radiation Syndrome (ARS) is a potentially lethal condition caused by high-dose radiation exposure

The use of cholesterol-lowering drugs known as statins to reduce the risk of heart disease has exploded in recent years, but the new Stanford study shows that doctors

Under the terms of the license agreement Pfizer will have the right to use the ACE System internally to engineer cell lines for product research, development and manufacturing.

The company began submitting data for the application in April 2005. The filings are based on clinical data supporting that both indiplon capsules and tablets show significant improvement

The European Medicines Agency’s (EMEA) Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion to extend the use of Arixtra (fondaparinux sodium) to patients judged